XTL Biopharmaceuticals Price Chart
XTL Biopharmaceuticals Volume Chart
XTL Biopharmaceuticals Market Segments
Regular Trading Hours
-0.07(-2.43%)
| Open | $2.83 |
|---|---|
| Close | $2.76 |
| Low | $2.68 |
| Low Change | -0.15 (-5.30%) |
| High | $2.88 |
| High Change | +0.05 (+1.77%) |
| Range | $0.20 |
| Volume | 3.422K |
| Dollar Volume | $9.45K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.02(+0.70%)
| Open | $2.86 |
|---|---|
| Close | $2.88 |
| Low | $2.79 |
| Low Change | -0.07 (-2.45%) |
| High | $2.88 |
| High Change | +0.02 (+0.70%) |
| Range | $0.09 |
| Volume | 890 |
| Dollar Volume | $2.56K |
Premarket Yesterday
*No Trades in Segment
XTL Biopharmaceuticals News
XTL Biopharmaceuticals Top Trades
XTL Biopharmaceuticals's top trade so far today returned +3.03%, while the top short trade returned -5.30%.
XTL Biopharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $2.88 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.87 |
| 20 Day Moving Average (SMA20) | $2.81 |
| 50 Day Moving Average (SMA50) | $2.59 |
| 100 Day Moving Average (SMA100) | $2.34 |
| 200 Day Moving Average (SMA200) | $1.64 |
XTL Biopharmaceuticals Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
XTL Biopharmaceuticals Stock Splits
There have been 2 stock splits for XTL Biopharmaceuticals (XTLB). The last reverse stock split occured on March 25, 2026 and reduced the outstanding shares at a ratio of 4:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 25, 2026 | Reverse | 4:1 |
| Feb 10, 2017 | Reverse | 5:1 |
XTL Biopharmaceuticals Dividends
There have been no dividends for XTL Biopharmaceuticals (XTLB).